Cell tracking velocimetry as a tool for defining saturation binding of magnetically conjugated antibodies

Cytometry Part A

Volumn 66, Issue 2, 2005, Pages 103-108

  Leigh, Diane R ^a   Steinert, Steffen ^a,b   Moore, Lee R ^a   Chalmers, Jeffrey J ^c   Zborowski, Maciej ^a  

^a LERNER RESEARCH INSTITUTE   (United States)

^b DRESDEN UNIVERSITY OF TECHNOLOGY   (Germany)

^c Ohio State University   (United States)

Author keywords

Cell separation; Cell tracking velocimetry; Flow cytometry; Immunomagnetic labeling; Magnetophoresis; Mobility

Indexed keywords

ANTIBODY; FLUORESCENT DYE;

ACCURACY; ANTIGEN BINDING; ARTICLE; CELL LABELING; CELL MOTILITY; CELL SELECTION; CELL SEPARATION; CELL TRACKING VELOCIMETRY; CONTROLLED STUDY; FLOW CYTOMETRY; FLUORESCENCE; HUMAN; HUMAN CELL; IMMUNOMAGNETIC SEPARATION; MAGNETISM; MAGNETOPHORESIS; PRIORITY JOURNAL; SEPARATION TECHNIQUE;

ANTIBODIES, MONOCLONAL; ANTIGEN-ANTIBODY REACTIONS; ANTIGENS, CD45; BINDING SITES, ANTIBODY; CELL MOVEMENT; FLOW CYTOMETRY; FLUORESCENT ANTIBODY TECHNIQUE; HUMANS; IMMUNOMAGNETIC SEPARATION; JURKAT CELLS; MAGNETICS; MICROSPHERES; PHYCOERYTHRIN; RHEOLOGY;

EID: 23044452142     PISSN: 15524922     EISSN: None     Source Type: Journal    
DOI: 10.1002/cyto.a.20155     Document Type: Article

References (31)

1. Racila E, Euhus D, Weiss AJ, Rao C, McConnell J, Terstappen LW, Uhr JW. Detection and characterization of carcinoma cells in the blood. Proc Natl Acad Sci USA 1998;95:4589-4594.
2. Naume B, Børgen E, Nesland JM, Beiske K, Gilen E, Renolen A, Ravnås G, Qvist H, Kåresen R, Kvalheim G. Increased sensitivity for detection of micrometastases in bone-marrow/peripheral-blood stem-cell products from breast cancer patients by negative immunomagnetic separation. Int J Cancer 1998;78:556-560.
3. Beitsch PD, Clifford E. Detection of carcinoma cells in the blood of breast cancer patients. Am J Surg 2000;180:446-449.
4. Moreno JG, O'Hara SM, Gross S, Doyle G, Fritsche H, Gomella LG, Terstappen LWMM. Changes in circulating carcinoma cells in patients with metastatic prostate cancer correlate with disease status. Urology 2001;58:386-392.
5. Lara O, Tong X, Zborowski M, Chalmers JJ. Enrichment of rare cancer cells through depletion of normal cells using density and flow-through, immunomagnetic cell separation. Exp Hematol 2004;32: 891-904.
6. Cristofanilli M, Budd GT, Ellis MJ, Stopeck A, Matera J, Miller MC, Reuben JM, Doyle GV, Allard WJ, Terstappen LWMM, Hayes DF. Circulating tumor cells, disease progression, and survival in metastatic breast cancer. N Engl J Med 2004;351:781-791.
7. Bruno A, Caravita T, Adorno G, Del Poeta G, Venditti A, Stasi R, Ballatore G, Del Proposto G, Lanti A, Zinno F, Cudillo L, Dentamaro T, Buccisano F, Tamburini A, Santinelli S, Maurillo L, Cantonetti M, Cox MC, Masi M, Catalano G, Isacchi G, Amadori S. Positive selection of CD34+ cells by immunoadsorption: factors affecting the final yield and hematopoietic recovery in patients with hematological malignancies and solid tumors. Transfus Apheresis Sci 2002;26:103-110.
8. Cornelissen JJ, van der Holt B, Petersen EJ, Vindelov L, Russel CA, Höglund M, Maertens J, Schouten HC, Braakman E, Steijaert MMC, Zijlmans MJM, Slaper-Cortenbach IC, Boogaerts MA, Löwenberg B, Verdonck LF. A randomized multicenter comparison of CD34+-selected progenitor cells from blood vs bone marrow in recipients of HLA-identical allogeneic transplants for hematological malignancies. Exp Hematol 2003;31:855-864.
9. Handgretinger R, Lang P, Schumm M, Taylor G, Neu S, Koscielnak E, Niethammer D, Klingebiel T. Isolation and transplantation of autologous peripheral CD34+ progenitor cells highly purified by magnetic-activated cell sorting. Bone Marrow Transplant 1998;21:987-993.
10. Lang P, Bader P, Schumm M, Feuchtinger T, Einsele H, Führer M, Weinstock C, Handgretinger R, Kuci S, Martin D, Niethammer D, Greil J. Transplantation of a combination of CD133+ and CD34+ selected progenitor cells from alternative donors. Br J Haematol 2004;124:72-79.
11. Vogel W, Scheding S, Kanz L, Brugger W. Clinical applications of CD34+ peripheral blood progenitor cells (PBPC). Stem Cells 2000; 18:87-92.
12. Moore LR, Zborowski M, Sun L, Chalmers JJ. Lymphocyte fractionation using immunomagnetic colloid and a dipole magnet flow cell sorter. J Biochem Biophys Methods 1998;37:11-33.
13. Chalmers JJ, Zborowski M, Sun L, Moore L. Flow through, immunomagnetic cell separation. Biotechnol Prog 1998;14:141-148.
14. Comella K, Nakamura M, Melnik K, Chosy J, Zborowski M, Cooper MA, Fehniger TA, Caligiuri MA, Chalmers JJ. Effects of antibody concentration on the separation of human natural killer cells in a commercial immunomagnetic separation system. Cytometry 2001;45:285-293.
15. Zagursky R, Sharp D, Solomon K, Schwartz A. Quantitation of cellular receptors by a new inimunocytochemical flow cytometry technique. Biotechniques 1995;18:504-509.
16. Bikoue A, George F, Poncelet P, Mutin M, Janossy G, Sampol J. Quantitative analysis of leukocyte membrane antigen expression: normal adult values. Cytometry 1996;26:137-147.
17. Guezennec YG, Brodkey RS, Trigui N, Kent JC. Algorithms for fully automated three-dimensional particle tracking velocimetry. Exp Fluids 1994;17:209-219.
18. Reddy S, Moore LR, Sun L, Zborowski M, Chalmers JJ. Determination of the magnetic susceptibility of labeled particles by video imaging. Chem Eng Sci 1996;6:947-956.
19. Chalmers JJ, Zhao Y, Nakamura M, Melnik K, Lasky L, Moore L, Zborowski M. An instrument to determine the magnetophoretic mobility of labeled, biological cells and paramagnetic particles. J Magn Magn Mater 1999;194:231-241.
20. McCloskey KE, Chalmers JJ, Zborowski M. Magnetophoretic mobilities correlate to antibody binding capacities. Cytometry 2000;40:307-315
21. (erratum Cytometry 2000;41:150).
22. Moore LR, Zborowski M, Nakamura M, McCloskey KE, Gura S, Zuberi M, Margel S, Chalmers JJ. Magnetophoretic mobility determination of monodispersed, magnetic microspheres by Cell Tracking Velocimetry. J Biochem Biophys Methods 2000;44:115-130.
23. Zborowski M, Ostera G, Moore LR, Milliron S, Chalmers JJ, Schechter AN. Red blood cell magnetophoresis. Biophys J 2003;84:2648-2655.
24. Shapiro HM. Practical flow cytometry. New York: Wiley-Liss; 1995.
25. Chalmers JJ, Haam S, Zhao Y, McCloskey K, Moore L, Zborowski M, Williams PS. Quantification of cellular properties from external fields and resulting induced velocity: magnetic susceptibility. Biotechnol Bioeng 1999;64:519-526.
26. Moore LR, Rodriguez AR, Williams PS, McCloskey KE, Bolwell BJ, Nakamura M, Chalmers JJ, Zborowski M. Progenitor cell isolation with a high-capacity quadrupole magnetic flow sorter. J Magn Magn Mater 2001;225:277-284.
27. Hoyos M, McCloskey KE, Moore LR, Nakamura M, Bolwell BJ, Chalmers JJ, Zborowski M. Pulse-injection studies of blood progenitor cells in a quadropole magnet flow sorter. Separ Sci Technol 2002; 37:745-767.
28. Chosy J, Melnik K, Comella K, Zborowski M, Chalmers JJ. Antibody saturation studies of three antigens proposed for use in rare cancer cell detection. Biotechnol Bioeng 2003;82:340-351.
29. Zhang H, Williams PS, Zborowski M, Chalmers JJ. The effect of magnetic nanoparticles on the binding affinity of antibody-antigen and streptavidin-biotin interactions. Unpublished manuscript; 2004.
30. Kim DK, Fujiki Y, Fukushima T, Ema H, Shibuya A, Nakauchi H. Comparison of hematopoietic activities of human bone marrow and umbilical cord blood CD34 positive and negative cells. Stem Cells 1999; 17:286-294.
31. Hubl W, Iturraspe J, Martinez GA, Hutcheson CE, Roberts CG, Fisk DD, Sugrue MW, Wingard JR, Braylan RC. Measurement of absolute concentration and viability of CD34+ cells in cord blood and cord blood products using fluorescent beads and cyanine nucleic acid dyes. Cytometry 1998;34:121-127.